MML Investors Services
ACAD icon

MML Investors Services’s Acadia Pharmaceuticals ACAD Stock Holding History

MML Investors Services’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.02M Buy
40,286
+3,763
+10% +$82.8K ﹤0.01% 2004
2026
Q1 		$813K Buy
36,523
+3,786
+12% +$90.5K ﹤0.01% 1906
2025
Q4 		$874K Buy
32,737
+10,426
+47% +$249K ﹤0.01% 1890
2025
Q3 		$476K Buy
22,311
+6,127
+38% +$145K ﹤0.01% 2205
2025
Q2 		$349K Buy
16,184
+5,382
+50% +$100K ﹤0.01% 2322
2025
Q1 		$179K Buy
+10,802
New +$196K ﹤0.01% 2569

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

MML Investors Services's ACAD Position: Q2 2026 in Review

MML Investors Services increased its Acadia Pharmaceuticals (ACAD) stake by 10% in Q2 2026, buying an estimated $82.8K and bringing the position to 40,286 shares worth $1.02M. The position accounts for ﹤0.01% of the portfolio, ranked #2004.

MML Investors Services first reported a position in ACAD in Q1 2025 and has held it in 6 quarters since. 354 funds tracked by Wall St. Rank hold ACAD as of Q2 2026.

  • MML Investors Services held 40,286 shares of Acadia Pharmaceuticals worth $1.02M as of Q2 2026.
  • MML Investors Services bought 3,763 Acadia Pharmaceuticals shares in Q2 2026, an estimated $82.8K.
  • Acadia Pharmaceuticals made up ﹤0.01% of MML Investors Services's portfolio in Q2 2026, its #2004 holding.
  • MML Investors Services first reported a position in Acadia Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
  • 354 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q2 2026.

Based on MML Investors Services's 13F filing for Q2 2026, filed 7 Aug 2026.